Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: France Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20091
20104
20112
20121
20132
20145
20153
20173
20183
20195
20205
20215
20223
20234
20244
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting14
Unknown status6
Terminated4
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris10
University Hospital, Bordeaux8
Novartis Pharmaceuticals6
argenx6
Amgen3
University Hospital, Toulouse3
Centre Hospitalier Universitaire Dijon2
Chugai Pharmaceutical2
GlaxoSmithKline2
UCB Biopharma SRL2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic60
Thrombocytopenia8
Lupus Erythematosus, Systemic4
Purpura4
Anemia, Hemolytic, Autoimmune3
Autoimmune Diseases3
Behcet Syndrome3
Antiphospholipid Syndrome2
Arthritis, Rheumatoid2
Dermatomyositis2

Trials

Showing 26 to 50 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.